Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis
Clinical trial NCT03066609 · COMPLETED
Trial details
- NCT number
- NCT03066609
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-28
- Primary completion
- 2017-12-21
- Enrollment
- 543
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.